TBVI is partner in ADITEC, a project to advance new immunisation technologies. Partners of this consortium are presenting the fourth course on adjuvants and vaccine formulation.
Dates: 15-19 June 2015
Location: Vaccine Formulation Laboratory at University of Lausanne, Switzerland
Various adjuvant systems, such as Aluminum salts / Water-in-Oil emulsions / Oil-in-Water emulsions / TLR agonists / Liposomes / Virosomes / QS21 / ISOMs
This 5-day course will focus on the different vaccine adjuvant systems and will give an overview on best practices in formulation of adjuvanted vaccines. In addition, background information on the immune system and process development, characterization, quality control, preclinical development, clinical development and regulatory aspects of adjuvanted vaccines will be provided.
Eligibility criteria: The course is open for both members of the ADITEC project, and for non-members. Only candidates working in the EU or associated member states are eligible to apply. They should have a BSc or MSc, or have demonstrable vaccine-related research experience.
The course will be open for a maximum of 12 participants.
Registration fees and costs: Participants’ course registration fees and hotel accommodation at Hôtel L’Union will be covered by the ADITEC project (reservations must be made through the course organizers). All other costs are the responsibility of the participant or their employer.
Application procedure: Applicants must use the application form. Applications must be written in English and submitted electronically to Lynn Zimmerman AND Laura Pacciarini using subject line “Adjuvant Formulation Course Application”. Applications can be submitted any time from now and must be successfully received by ADITEC no later than 28 February 2015 at 5pm GMT.
Evaluation and selection of candidates will be performed by the ADITEC Training Steering Committee. Candidates will be informed about the outcome of their application latest by 6 April 2015.
For more information on the course content contact Dr Maria Lawrenz.